These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
458 related items for PubMed ID: 24399811
1. Mycophenolate mofetil in the treatment of SLE and systemic vasculitis: experience at a single university center. Lourdudoss C, Vollenhoven Rv. Lupus; 2014 Mar; 23(3):299-304. PubMed ID: 24399811 [Abstract] [Full Text] [Related]
2. Mycophenolate mofetil in low doses stabilizes and improves antineutrophil cytoplasmic antibody-associated vasculitis and lupus nephritis. Kazderova M, Jancova E, Rysava R, Merta M, Tesar V. Arch Med Res; 2008 Jan; 39(1):115-9. PubMed ID: 18068004 [Abstract] [Full Text] [Related]
3. Experience with mycophenolate mofetil as maintenance therapy in five pediatric patients with severe systemic lupus erythematosus. Dittrich K, Ross S, Benz K, Amann K, Dötsch J. Klin Padiatr; 2009 Dec; 221(7):425-9. PubMed ID: 20013565 [Abstract] [Full Text] [Related]
4. Does mycophenolate mofetil prevent extra-renal flares in systemic lupus erythematosus? Results from an observational study of patients in a single practice treated for up to 5 years. Posalski JD, Ishimori Ml, Wallace DJ, Weisman MH. Lupus; 2009 May; 18(6):516-21. PubMed ID: 19395453 [Abstract] [Full Text] [Related]
5. Mycophenolate mofetil in systemic lupus erythematosus: results from a retrospective study in a large monocentric cohort and review of the literature. Conti F, Ceccarelli F, Perricone C, Massaro L, Cipriano E, Pacucci VA, Truglia S, Miranda F, Morello F, Alessandri C, Spinelli FR, Valesini G. Immunol Res; 2014 Dec; 60(2-3):270-6. PubMed ID: 25468307 [Abstract] [Full Text] [Related]
6. Open label randomized controlled trial assessing the efficacy of mycophenolate sodium against other conventional immunosuppressive agents in active systemic lupus erythematosus patients without renal involvement. Yahya F, Jasmin R, Ng CT, Cheah TE, Sockalingam S. Int J Rheum Dis; 2013 Dec; 16(6):724-30. PubMed ID: 24119227 [Abstract] [Full Text] [Related]
7. Tolerability of mycophenolate mofetil in patients with systemic lupus erythematosus. Riskalla MM, Somers EC, Fatica RA, McCune WJ. J Rheumatol; 2003 Jul; 30(7):1508-12. PubMed ID: 12858449 [Abstract] [Full Text] [Related]
8. Hypersensitivity to mycophenolate mofetil in systemic lupus erythematosus: diagnostic measures and successful desensitization. Szyper-Kravitz M, Sheinberg P, Sidi Y, Schiffenbauer Y, Trubniykov E, Shoenfeld Y. Int Arch Allergy Immunol; 2005 Dec; 138(4):334-6. PubMed ID: 16224194 [Abstract] [Full Text] [Related]
9. Real-World Experience of Safety of Mycophenolate Mofetil in 119 Japanese Patients with Systemic Lupus Erythematosus: A Retrospective Single-Center Study. Abe Y, Tada K, Yamaji K, Tamura N. Biomed Res Int; 2021 Dec; 2021():8630596. PubMed ID: 33564682 [Abstract] [Full Text] [Related]
10. A national survey on current use of mycophenolate mofetil for childhood-onset systemic lupus erythematosus in Japan. Hara R, Miyazawa H, Nishimura K, Momoi T, Nozawa T, Kikuchi M, Sakurai N, Kizawa T, Shimamura S, Yasuda S, Hiromura K, Sada KE, Kawaguchi Y, Tamura N, Takei S, Takasaki Y, Atsumi T, Mori M. Mod Rheumatol; 2015 Dec; 25(6):858-64. PubMed ID: 26215483 [Abstract] [Full Text] [Related]
11. [The efficacy of mycophenolate mofetil for systemic lupus erythematosus]. Suzuki D, Ogawa N, Sawada J, Kimoto O, Shimoyama K, Hayashi H. Nihon Rinsho Meneki Gakkai Kaishi; 2009 Aug; 32(4):263-8. PubMed ID: 19721347 [Abstract] [Full Text] [Related]
12. Mycophenolate mofetil is effective in reducing disease flares in systemic lupus erythematosus patients: a retrospective study. Nannini C, Crowson CS, Matteson EL, Moder KG. Lupus; 2009 Apr; 18(5):394-9. PubMed ID: 19318390 [Abstract] [Full Text] [Related]
13. Mycophenolate mofetil as maintenance therapy for childhood-onset systemic lupus erythematosus patients with severe lupus nephritis. Kizawa T, Nozawa T, Kikuchi M, Nagahama K, Okudela K, Miyamae T, Imagawa T, Nakamura T, Mori M, Yokota S, Tsutsumi H. Mod Rheumatol; 2015 Mar; 25(2):210-4. PubMed ID: 25159157 [Abstract] [Full Text] [Related]
15. Mycophenolate mofetil for refractory haemolytic anemia in systemic lupus erythematosus. Mak A, Mok CC. Lupus; 2005 Mar; 14(10):856-8. PubMed ID: 16302683 [Abstract] [Full Text] [Related]
16. Effective plasma concentrations of mycophenolic acid and its glucuronide in systemic lupus erythematosus patients in the remission-maintenance phase. Mino Y, Naito T, Shimoyama K, Ogawa N, Kawakami J. J Clin Pharm Ther; 2012 Apr; 37(2):217-20. PubMed ID: 21517926 [Abstract] [Full Text] [Related]
17. Mycophenolate Mofetil and New-Onset Systemic Lupus Erythematosus: A Randomized Clinical Trial. You Y, Zhou Z, Wang F, Li J, Liu H, Cheng X, Su Y, Chen X, Zheng H, Sun Y, Shi H, Hu Q, Xu J, Teng J, Yang C, Ye J. JAMA Netw Open; 2024 Sep 03; 7(9):e2432131. PubMed ID: 39283640 [Abstract] [Full Text] [Related]
18. Mycophenolate mofetil in the treatment of systemic lupus erythematosus. Dall'Era M. Curr Opin Rheumatol; 2011 Sep 03; 23(5):454-8. PubMed ID: 21720247 [Abstract] [Full Text] [Related]
19. Efficacy of mycophenolate mofetil in Japanese patients with systemic lupus erythematosus. Kawazoe M, Kaneko K, Yamada Z, Masuoka S, Mizutani S, Yamada S, Shikano K, Sato H, Kaburaki M, Muraoka S, Kawai S, Nanki T. Clin Rheumatol; 2019 Jun 03; 38(6):1571-1578. PubMed ID: 30778862 [Abstract] [Full Text] [Related]
20. Mycophenolate mofetil-induced erythroid hypoplasia in a patient with systemic lupus erythematosus. Doherty T, Austin SK, Newell B, Kiely PD. Lupus; 2013 Feb 03; 22(2):213-5. PubMed ID: 23257406 [Abstract] [Full Text] [Related] Page: [Next] [New Search]